Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.
A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.
It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.
GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.
The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.
Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.
What was described by a University of California professor as gene therapy's "single most remarkable achievement?"
AI opens up new opportunities in R&D – and also provides pharma companies with new ways to connect with patients for better outcomes.
How can we prevent the retinal degradation caused by geographic atrophy?
Cristina del Carmen Rosello
What does the future hold for Tregs? Treg-cell therapy could transform the way we treat autoimmune disease and transplant rejection.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
X2: Researchers United
Autoinjectors: Through Thick and Thin
Staying on the Track to Eradication